Tosoh, Gen-Probe Sign Cross-Licensing Agreement For Nucleic Acid Testing Technologies
Tosoh will receive non-exclusive rights to Gen-Probe's proprietary transcription-mediated amplification (TMA) and ribosomal RNA technologies in exchange for two payments in 2004. Additionally, Tosoh will pay Gen-Probe royalties on worldwide sales of products that employ the licensed Gen-Probe technologies.
Gen-Probe will gain access, in exchange for royalties, to Tosoh's patented TRC (Transcription reverse-transcription concerted) amplification and INAF (Intercalation activating fluorescence) detection technologies for use with real time TMA.
"The combination of proprietary technologies from Tosoh and Gen-Probe will further support our strategy of positioning Tosoh Bioscience in new emerging growth markets. We look forward to continuing our collaboration with Gen-Probe as Tosoh introduces more products in the future," said Madoka Tashiro, Chairman and CEO of Tosoh Corporation.
"This agreement with Tosoh enables us to realize additional value from our broad patented technologies, gain additional income from new market segments we are not currently targeting, and access additional innovative NAT technologies," said Henry L. Nordhoff, chairman, president and CEO of Gen-Probe.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.